Association Between the Use of Long-Acting Insulin and Hypoglycemia in Critically Ill Patients with Diabetes
Journal of Intensive Care Medicine · 2025
DOI: 10.1177/08850666251371709 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Intensive Care Medicine, 2025. Verfasst von Amina Ammar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Eugene Applebaum College of Pharmacy & Health Sciences, Wayne State University, Detroit, MI, USA. Hauptthemen laut MEDLINE: Hypoglycemia, Critical Illness, Hypoglycemic Agents, Diabetes Mellitus, Type 2. Die Arbeit nennt 25 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Introduction
Hypoglycemia in critically ill patients increases morbidity and mortality. Subcutaneous long-acting insulin (LAI) in patients without diabetes is associated with hypoglycemia in the SICU. However, limited evidence exists in patients with diabetes.
Methods
This was a single-center, retrospective cohort study evaluating patients with T2DM who were admitted to the SICU for 24 h and received LAI in combination with sliding scale insulin (LAI + SSI) or sliding scale insulin (SSI) alone. The primary outcome was the incidence of hypoglycemia (BG < 70 mg/dL) in patients who received LAI + SSI or SSI. Secondary outcomes evaluated the number of glucose values across defined categories: hypoglycemia (54-70 mg/dL), severe hypoglycemia (180 mg/dL) and glycemic variability.
Results
A total of 228 patients were included in the final analysis. The incidence of hypoglycemia occurred in 17.5% of patients in the LAI + SSI cohort and 18.4% in the SSI cohort (p = .86). After controlling for confounders, no differences were observed with LAI + SSI versus SSI for hypoglycemia (OR 1.09, 95% CI 0.46-2.6, p = .85). Secondary outcomes demonstrated no difference in total hypoglycemia (37 vs 31, p = .80), severe hypoglycemia (15 vs 34, p = .17) and euglycemia (1622 vs 1780, p = .22) in the LAI + SSI cohort compared to SSI alone. Hyperglycemia occurred more frequently with LAI + SSI. However, after adjusting for confounders there was no difference in hyperglycemia (OR 1.8, 95% CI 0.7-4.6, p = .22). No difference was observed in glycemic variability between LAI + SSI and SSI (26.5 vs 24.5, p = .21). Conclusion and Relevance: The addition of LAI to SSI in SICU patients with T2DM was not associated with an increased risk of hypoglycemia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Eugene Applebaum College of Pharmacy & Health Sciences, Wayne State University, Detroit, MI, USA.
- Department of Pharmacy, Henry Ford St. John Hospital, Detroit, MI, USA.
- Present address: Department of Pharmacy, Henry Ford Providence Southfield Hospital, Southfield, MI, USA.
ORCID-Profile: Amina Ammar, Christopher Giuliano
Zitieren
APA
Ammar, A., Sorochak, N., Paxton, R., Lipari, M., & Giuliano, C. (2025). Association Between the Use of Long-Acting Insulin and Hypoglycemia in Critically Ill Patients with Diabetes. Journal of Intensive Care Medicine. https://doi.org/10.1177/08850666251371709
Vancouver
Ammar A, Sorochak N, Paxton R, Lipari M, Giuliano C. Association Between the Use of Long-Acting Insulin and Hypoglycemia in Critically Ill Patients with Diabetes. Journal of Intensive Care Medicine. 2025. doi:10.1177/08850666251371709
BibTeX
@article{Ammar2025,
author = {Ammar, Amina and Sorochak, Nataliya and Paxton, Renee and Lipari, Melissa and Giuliano, Christopher},
title = {Association Between the Use of Long-Acting Insulin and Hypoglycemia in Critically Ill Patients with Diabetes},
journal = {Journal of Intensive Care Medicine},
year = {2025},
doi = {10.1177/08850666251371709}
}
EUVIMED